JPMorgan Chase & Co. decreased its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 13.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 46,280 shares of the medical instruments supplier’s stock after selling 7,313 shares during the period. JPMorgan Chase & Co.’s holdings in Mettler-Toledo International were worth $26,613,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Signaturefd LLC acquired a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $111,000. Alps Advisors Inc. acquired a new position in Mettler-Toledo International during the first quarter valued at approximately $202,000. Campbell & CO Investment Adviser LLC acquired a new position in Mettler-Toledo International during the first quarter valued at approximately $251,000. We Are One Seven LLC acquired a new position in Mettler-Toledo International during the fourth quarter valued at approximately $427,000. Finally, Canandaigua National Bank & Trust Co. acquired a new position in Mettler-Toledo International during the first quarter valued at approximately $397,000. Institutional investors own 92.32% of the company’s stock.

MTD has been the subject of a number of analyst reports. Goldman Sachs Group cut shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating in a report on Monday, April 9th. Morgan Stanley decreased their price objective on shares of Mettler-Toledo International from $595.00 to $568.00 and set an “equal weight” rating for the company in a report on Wednesday, April 11th. Zacks Investment Research upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $640.00 price objective for the company in a report on Wednesday, April 11th. Deutsche Bank boosted their price objective on shares of Mettler-Toledo International from $600.00 to $630.00 and gave the company a “hold” rating in a report on Thursday, March 1st. Finally, Cleveland Research cut shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating in a report on Tuesday, May 1st. Nine investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $632.00.

In other news, Director Wah-Hui Chu sold 1,150 shares of the company’s stock in a transaction that occurred on Thursday, June 7th. The shares were sold at an average price of $587.83, for a total value of $676,004.50. Following the completion of the transaction, the director now owns 3,278 shares in the company, valued at $1,926,906.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael Heidingsfelder sold 2,562 shares of the company’s stock in a transaction that occurred on Thursday, June 7th. The shares were sold at an average price of $590.00, for a total transaction of $1,511,580.00. Following the completion of the transaction, the insider now owns 1,840 shares of the company’s stock, valued at approximately $1,085,600. The disclosure for this sale can be found here. Insiders sold 18,934 shares of company stock valued at $10,795,962 in the last quarter. Corporate insiders own 4.80% of the company’s stock.

Mettler-Toledo International stock opened at $595.14 on Wednesday. The company has a market capitalization of $15.04 billion, a PE ratio of 33.87, a P/E/G ratio of 2.26 and a beta of 1.19. Mettler-Toledo International Inc. has a twelve month low of $540.24 and a twelve month high of $697.26. The company has a quick ratio of 1.02, a current ratio of 1.46 and a debt-to-equity ratio of 1.75.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, May 3rd. The medical instruments supplier reported $3.74 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.73 by $0.01. The company had revenue of $660.82 million during the quarter, compared to analysts’ expectations of $651.87 million. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.34 earnings per share. equities research analysts predict that Mettler-Toledo International Inc. will post 20.25 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.